Evelyn Glotzbach-Schoon1 Marta Andreatta1 Andreas Reif2 Heike Ewald1 Christian Tröger1 Christian Baumann1,2 Jürgen Deckert2 Andreas Mühlberger1,3 Paul Pauli1*- 1Department of Psychology I, Biological Psychology, Clinical Psychology, and Psychotherapy, University of Würzburg, Würzburg, Germany
- 2Department of Psychiatry, Psychosomatics, and Psychotherapy, University of Würzburg, Würzburg, Germany
- 3Department of Psychology, Chair of Clinical Psychology, and Psychotherapy, University of Regensburg, Regensburg, Germany
The serotonin (5-HT) and neuropeptide S (NPS) systems are discussed as important genetic modulators of fear and sustained anxiety contributing to the etiology of anxiety disorders. Sustained anxiety is a crucial characteristic of most anxiety disorders which likely develops through contextual fear conditioning. This study investigated if and how genetic alterations of the 5-HT and the NPS systems as well as their interaction modulate contextual fear conditioning; specifically, function polymorphic variants in the genes coding for the 5-HT transporter (5HTT) and the NPS receptor (NPSR1) were studied. A large group of healthy volunteers was therefore stratified for 5HTTLPR (S+ vs. LL carriers) and NPSR1 rs324981 (T+ vs. AA carriers) polymorphisms resulting in four genotype groups (S+/T+, S+/AA, LL/T+, LL/AA) of 20 participants each. All participants underwent contextual fear conditioning and extinction using a virtual reality (VR) paradigm. During acquisition, one virtual office room (anxiety context, CXT+) was paired with an unpredictable electric stimulus (unconditioned stimulus, US), whereas another virtual office room was not paired with any US (safety context, CXT−). During extinction no US was administered. Anxiety responses were quantified by fear-potentiated startle and ratings. Most importantly, we found a gene × gene interaction on fear-potentiated startle. Only carriers of both risk alleles (S+/T+) exhibited higher startle responses in CXT+ compared to CXT−. In contrast, anxiety ratings were only influenced by the NPSR1 polymorphism with AA carriers showing higher anxiety ratings in CXT+ as compared to CXT−. Our results speak in favor of a two level account of fear conditioning with diverging effects on implicit vs. explicit fear responses. Enhanced contextual fear conditioning as reflected in potentiated startle responses may be an endophenotype for anxiety disorders.
Introduction
Associative learning processes are crucial for the development of anxiety disorders (Mineka and Zinbarg, 2006). Cued fear conditioning which is a simple form of associative learning is regarded as a model for phasic fear and phobias (Grillon, 2002). In cued fear conditioning, a discrete cue (conditioned stimulus, CS) is predictably paired with an aversive event (unconditioned stimulus, US). By contrast, contextual fear conditioning may serve as a model for sustained and chronic anxiety because the US is not time-bound to a specific cue and is, therefore, experienced as an unpredictable event (Grillon, 2008). Animal and human studies demonstrate that sustained fear responses to contexts associated with unpredictable stressors are mediated by the amygdala, specifically by the bed nucleus of the stria terminalis (BNST) and the hippocampus (Alvarez et al., 2008, 2011; Marschner et al., 2008; Barot et al., 2009; Luyten et al., 2011). Importantly, it has been suggested that increased contextual anxiety elicited by unpredictable aversive events may be an important pathogenic marker for panic disorder and post-traumatic stress disorder (PTSD) (Grillon et al., 2008, 2009).
Although, threatening experiences and life stress have been reported to increase the risk for anxiety disorders (Watanabe et al., 2005; Melchior et al., 2007), the effect of environmental stress is also moderated by a genetic diathesis (Nugent et al., 2011). Supporting this view, a genetic contribution to the etiology of anxiety disorders (Gordon and Hen, 2004; Leonardo and Hen, 2006) and to fear conditioning (Merrill et al., 1999; Hettema et al., 2003; Lonsdorf and Kalisch, 2011) has been demonstrated. Especially, a polymorphism within the promoter region of the serotonin transporter (5-HTT) gene (SLC6A4, 5HTT) located on chromosome 17q11.1-q12 has been shown to play an important role in trait anxiety and anxiety disorders (Lesch et al., 1996; Amstadter et al., 2009; Skelton et al., 2012). The short (S) allele of the 5HTT gene polymorphism (5HTTLPR) results in less expression of 5HTT mRNA presumably leading to reduced serotonin reuptake compared to the long (L) variant (Hariri and Holmes, 2006). The S allele is associated with high trait anxiety and heightened amygdala activation toward emotional stimuli (Hariri et al., 2002; Heinz et al., 2005; Canli and Lesch, 2007; Dannlowski et al., 2010). Studies on cued fear conditioning using startle reflex as an indicator of learned fear reveal stronger fear conditioning in S compared to LL allele carriers (Lonsdorf et al., 2009; Klumpers et al., 2012), though the down regulation of fear after the offset of a fear cue (CS+) is not affected by the 5HTTLPR polymorphism (Klumpers et al., 2012). These findings suggest that S allele carriers are characterized by faster fear learning and/or stronger fear reactivity than LL allele carriers, but fear regulation does not seem to be influenced by this genotype. Interestingly, the extinction of fear-potentiated startle in S allele carriers is additionally influenced by the COMTval158met polymorphism of the catechol-O-methyltransferase gene (COMT). Only those S allele carriers who additionally carried two met alleles (met/met) of the COMTval158met polymorphism exhibit enhanced startle responses to CS+ during extinction, which demonstrates a gene × gene interaction implicated in fear extinction (Lonsdorf et al., 2009).
The recently discovered neuropeptide S (NPS) and its receptor (NPSR) also seem to impact arousal, fear, and anxiety responses. NPSR mRNA has been found to be highly expressed in the amygdala, hippocampus and paraventricular hypothalamic nucleus in the rat brain (Xu et al., 2007; Jüngling et al., 2008). NPS binding to its receptor leads to increased glutamatergic transmission to intercalated GABAergic neurons in the amygdala (Jüngling et al., 2008). In rodents, NPS injection is found to have anxiolytic effects namely the reduction of contextual anxiety, cued fear, and enhancement of fear extinction (Jüngling et al., 2008; Meis et al., 2008; Fendt et al., 2010; Pape et al., 2010). A single nucleotide polymorphism (SNP; rs324981) in the human NPS receptor gene, NPSR1, leads to an amino-acid exchange from Asn to Ile at position 107 of the protein resulting in potentiated efficacy of NPS at NPSR in the T allele (Ile107) compared to the A allele (Asn107) carriers (Reinscheid et al., 2005). Studies in humans suggest that rs324981 is associated with anxiety disorders, as the more active T allele is associated with panic disorder in females (Domschke et al., 2011). In healthy volunteers, T allele carriers exhibit increased basolateral amygdala activation to fearful faces (Dannlowski et al., 2011), and report generally enhanced fear ratings to both a fear (CS+) and a safety signal (CS−) during a cued fear conditioning paradigm thus T and homozygous AA carriers do not differ in differential fear learning (Raczka et al., 2010).
In conclusion, both the S and the T alleles of the 5HTTLPR and NPSR1 polymorphisms, seem to enhance the vulnerability to anxiety levels and/or anxiety disorders, but only the S allele influences differential cued fear conditioning (Lonsdorf et al., 2009; Raczka et al., 2010). However, while cue conditioning is a good model for phobic fear, contextual fear learning is a better model for sustained anxiety, and recent animal studies suggest the importance of these two polymorphisms for contextual fear conditioning. For instance, 5HTT knockout mice display enhanced contextual fear conditioning and impaired fear extinction compared to wild-type mice (Dai et al., 2008), and NPSR1 knockout mice exhibit enhanced freezing to a fear context (Fendt et al., 2011).
The present study is designed to examine a gene × gene interaction of 5HTTLPR and NPSR1 polymorphisms on contextual fear conditioning and extinction. We use a virtual reality (VR) paradigm with two virtual office rooms serving as conditioned contexts (Glotzbach et al., 2012; Tröger et al., 2012). Importantly, we assess fear responses on a verbal (ratings), a behavioral (fear-potentiated startle), and a physiological level (skin conductance). A valid behavioral measure of fear and anxiety which can be used across species is the fear-potentiated startle response (Fendt and Fanselow, 1999; Blumenthal et al., 2005). Startle responses, which can be measured in humans by means of an electromyogram of the M. orbicularis oculi (Blumenthal et al., 2005), are potentiated by influences of the central amygdala (CeA) on the caudal pontine reticular nucleus (PnC) (for reviews see Koch, 1999; Davis, 2006). Thus, negative, threatening, and fear inducing events lead to startle potentiation (Lang et al., 1990). As the fear-potentiation of the startle reflex occurs without cortical processes, it is thought to be an implicit measure of fear which is greatly independent of cognitive processes (Hamm et al., 2003; Hamm and Weike, 2005). In contrast, fear ratings are considered an explicit measure of fear, and skin conductance is considered a physiological measure of arousal (Bradley and Lang, 2007).
To disentangle genetic contributions to contextual fear conditioning, we here specifically probe a potential gene × gene interaction of 5HTTLPR and NPSR1 and hypothesize that carriers of both risk alleles (S and T) are characterized by an enhanced acquisition of contextual anxiety compared to no-risk allele carriers (LL or AA).
Materials and Methods
Sample
Ninety-three (Caucasian descent, 60 female; mean age 23.96 years, SD = 3.14) healthy subjects were drawn from a larger sample (N = 497) ascertained within the framework of the collaborative research center SFB TRR 58 (Domschke et al., 2012). For genotyping, a blood sample (18 ml EDTA blood) was collected from each participant. Participants were excluded if they had current or prior diagnosis of DSM-IV axis-I (using the Mini-International Neuropsychiatric Interview (MINI), Sheehan et al., 1998; German version: Ackenheil et al., 1999), any neurological or somatic disorder, illegal drug consumption (assessed by a urine drug screening for amphetamine, barbiturates, benzodiazepines, cocaine, ecstasy, methamphetamine, methadone, opiates, tricyclic antidepressants, tetrahydrocannabinol), alcohol consumption of more than 140 g per week, daily smoking of more than 20 cigarettes per day, daily use of any medication (except for hormonal contraception), pregnancy and left handedness. For the present study, we additionally excluded psychology students because of their familiarity with conditioning protocols.
Prior to genotyping, participants completed the Trait version of the State-Trait-Anxiety-Inventory (STAI; Spielberger et al., 1970; German version: Laux et al., 1981), the Anxiety-Sensitivity-Index (ASI; Reiss et al., 1986; German version: Alpers and Pauli, 2001), and the Behavioral Inhibition System and Behavioral Approach System (BIS-BAS; Carver and White, 1994; German version: Strobel et al., 2001). Life stress history was assessed with a 27-item self-report questionnaire regarding work, relocation and house renovation, financial and legal problems, own serious illness or of a friend or family member, physical or sexual abuse, etc. (see Canli et al., 2006; Herrmann et al., 2009). Participants had to indicate how many of these stressful life events they had experienced, and a sum score was calculated.
All participants gave their written informed consent. Participants gained €50 for their participation. The study was approved by the Ethics Committee of the Medical Faculty of the University of Würzburg. Thirteen participants had to be excluded because of technical problems (n = 7), low startle reactivity (n = 3), and excessive artifacts in startle data (n = 2; for startle response quantification see Data Reduction), and VR simulator sickness (n = 1). Thus, the final sample consisted of 80 participants.
Genotyping
Subjects were genotyped for 5HTTLPR and NPSR rs324981 A/T (Asn107Ile) polymorphisms as reported by Domschke et al. (2011) and Klauke et al. (2011). Subjects with one or two S alleles of the 5HTTLPR polymorphism were grouped together (S+). Similarly, subjects with one or two T alleles of the NPSR1 polymorphism (T+) were grouped like in previous studies (Hariri et al., 2002; Lonsdorf et al., 2009; Raczka et al., 2010; Domschke et al., 2011) resulting in the following four combined genotype groups: S+/T+, S+/AA, LL/T+, and LL/AA. The experimenter was blind to genotype.
Stimuli, Apparatus, and Design
A detailed description of the VR equipment, context stimuli, US, recording of physiological data, and procedure and design is published elsewhere (Tröger et al., 2012; Glotzbach-Schoon et al., 2013). In brief, the VR environment was created with the Source Engine (Valve Corporation, Bellevue, USA). Two different virtual office rooms served as different contexts (Figure 1). The VR environment, instructions, and ratings were presented with a Z800 3D Visor head-mounted display (HMD; eMagin, Hopewell Junction, USA). The head position was monitored by an electromagnetic tracking device (Patriot, Polhemus Corp., Colchester, USA) in order to adapt the field of view to head movements and to assess head orientation. The experimental procedure was controlled by the software Cyber Session (version 5.3.38), developed in the Department of Psychology I, University of Würzburg.
Figure 1. Screenshots of the two office rooms and the connecting corridor (intertrial–interval, ITI). During acquisition one office room was paired with mildly painful electrical stimuli (anxiety context, CXT+), whereas the other office room was never paired with electrical stimuli (safety context, CXT−).
The US was an electric stimulus generated by a constant current stimulator (Digitimer DS7A, Digitimer Ltd., Welwyn Garden City, UK) and triggered with a frequency of 50 Hz and a duration of 200 ms by the software Cyber Session. The electric stimulus was applied by a surface electrode placed on the dominant forearm. The intensity of the current was individually adjusted to each participant's pain threshold as done previously (Andreatta et al., 2010) and increased by 30% to avoid habituation. Neither current intensity nor pain ratings of the US (on a scale with anchors at 0 = no feeling at all, 4 = just noticeable pain, and 10 = very strong pain) were influenced by genotype (all ps > 0.2; see Table 1). However, there was a group effect of NPSR1 polymorphism on US arousal (on a scale from 0 = no arousal at all to 100 = very high arousal) and a trend for US valence rating (on a scale from 0 = very negative to 100 = very positive). AA carriers rated the US as more arousing (M = 54.40, SD = 21.99), F(1, 76) = 5.34, p = 0.024, η2p = 0.07, and by trend as more negative (M = 35.25, SD = 16.52), F(1, 76) = 3.40, p = 0.069, η2p = 0.04, than T+ carriers (arousal: M = 42.62, SD = 23.37; valence: M = 41.88, SD = 15.43).
Table 1. Demographic and psychometric data for genotype groups.
Startle probes of 50 ms, 103 dB (A) white noise were presented for physiological measures. Startle reflex was measured by electromyographic activity (EMG) from the M. orbicularis oculi with electrodes placed centrally under and next to the lateral canthus of the left eye. Ground and reference electrodes were placed at the mastoids. Impedances were kept below 10 kΩ. The EMG signal was filtered online with a 50 Hz notch filter and sampled at 1000 Hz. At the beginning of the experiment, four startle tones were presented at intervals of 15–17 s to reduce the initial startle reactivity. Skin conductance level (SCL) was measured on the thenar of the nondominant hand by two Ag-AgCl electrodes. Physiological data were recorded by Vision Recorder software (Brain Products Inc., Munich, Germany).
The experiment was run on two consecutive days separated by 24 h (see Figure 2). Two acquisition phases (Acquisition 1, Acquisition 2) were performed on Day 1 with US administered only in one office room (anxiety context, CXT+) but not in the other (safety context, CXT−). The corridor served as a control context and as an intertrial–interval (ITI) between CXT+ and CXT− during each run. On Day 2, two extinction phases (Extinction 1, Extinction 2) were conducted, where no US was presented. Before the experimental sessions of each day, participants were required to complete the State version of the STAI and the Positive And Negative Affect Schedule (PANAS; Watson et al., 1988; German version: Krohne et al., 1996). Day 1 started with a pre-acquisition phase; participants explored each virtual office room for 2 min by actively moving themselves through the VR using a joystick. Subsequently, two successive acquisition phases were started with each phase consisting of three presentations per context category (CXT+, CXT−, ITI). Participants were passively moved through the VR environment i.e., they could not influence the way through the office rooms and corridor. However, participants were always able to adapt their line of sight in the VR by head movements. The passages through CXT+ and CXT− lasted about 85 s each; the ITI passage lasted about 35 s. Fifteen startle probes were presented per context and nine startle probes during ITI at intervals of 10–34 s. Participants received 1–3 mildly painful electric stimuli in CXT+ but never in CXT−, resulting in a total of 12 electric stimuli during acquisition. The US was unpredictably presented at different locations in CXT+ preventing participants from associating specific cues within this context with shock administration. The office rooms were randomly assigned to the two conditions (CXT+ vs. CXT−) and counterbalanced across participants and groups. The sequence of context presentations was pseudo-random and also counterbalanced across participants and groups. Before the first acquisition phase, participants were instructed to figure out the relationship between the context and the US (Schiller et al., 2010). The experimental session on Day 2 was nearly the same. All electrodes were attached, including the one for the US presentation. Two extinction blocks were conducted where no US was administered. Like on Day 1, each block consisted of three runs where participants were passively moved through each context once. The same number of startle tones was presented during CXT+, CXT−, and ITI presentations as on Day 1.
Figure 2. Design of the contextual fear conditioning paradigm. Day 1 started with a pre-acquisition phase (Pre A) in which participants actively explored each context once by using a joystick. During the acquisition phases, one to three electric stimuli (US) per visit were presented in the anxiety context (CXT+). In the safety context (CXT−) no electric stimuli were administered. During extinction on Day 2, no electric stimuli were given. The acquisition phases as well as the extinction phases consisted of two blocks each (A1 and A2, E1 and E2). Participants were passively guided through the contexts on pre-recorded paths. They always enter one context, were then guided through the corridor (intertrial-interval, ITI) into the other context. After the consecutive presentation of the three conditions, the display turned black. This procedure was repeated three times during one block. Two to three startle probes were presented during each context presentation, and one to two startle probes during the ITI. After each phase, ratings were obtained. The order of the presentation of the different contexts was counterbalanced across participants and genotype groups.
Ratings for anxiety and US-expectancy for the two conditioned contexts (CXT+, CXT−) were obtained after the different phases of the experiment regarding the previously experienced phase (Day 1: pre-acquisition, Acquisition 1, Acquisition 2; Day 2: Extinction 1, Extinction 2). Rating scales ranged from 0 (no anxiety at all/no expectancy at all) to 100 (very high anxiety/definitely expected). Awareness of the CXT+ US contingency was assessed with an open question (“In which room did you receive electrical stimuli?”) after Acquisition 1 and 2 of Day 1 and participants had to describe the room. If participants described only the CXT+ they were labeled as “aware,” whereas if they stated that in both contexts any US was administered (CXT+ and CXT−) they were labeled as “uncertain.” In total, there were nine uncertain participants who were equally distributed over 5HTTLPR (S+: n = 5; LL: n = 4), χ2(1, N = 80) = 0.13, p = 0.723 and NPSR1 genotype groups (T+: n = 5; AA: n = 4), χ2(1, N = 80) = 0.13, p = 0.723.
Data Reduction
Startle response
Eyeblink EMG Data were processed with Vision Analyzer software (Brain Products Inc., Munich, Germany). The signal of orbital electrodes was filtered offline with a 500 Hz High Cut off and a 30 Hz Low Cut off Filter. The signal was rectified, smoothed (50 ms moving window average), and baseline corrected (50 ms before startle probe onset). The peak magnitude was identified within a time window from 20 to 200 ms after the probe onset. Artifact rejection was made by hand through excluding responses with baseline shifts above or below 5 μV and pre-blinks 50 ms before probe onsets higher than 5 μV. Magnitudes smaller than 5 μV were coded as zero. Responders vs. non-responders were defined on the basis of sufficient valid responses, which were artifact free and higher than 5 μV. If there were less than two valid responses per stimulus category (CXT+, CXT−, ITI) in a given phase (Acquisition 1, Acquisition 2, Extinction 1, and Extinction 2), the participant was excluded from further analysis. There were 5 participants who were excluded due to these criteria. Magnitudes in the acquisition and extinction phases were standardized into T-scores for each participant.
Skin conductance level
SCL data was filtered with 1 Hz High Cut-off. The mean tonic SCL was computed over each context presentation (excluding epochs from US presentation to 10 s after US presentation to avoid an increased SCL due to US presentation). SCL data were log-transformed [log10(SCL+1)] to normalize the distribution.
Statistical analysis
Prior to statistical analysis physiological data were averaged for each phase (Acquisition 1, Acquisition 2, Extinction 1, and Extinction 2) across three runs. Fear-potentiated startle was determined as the difference score between the mean startle response during contexts and ITI (CXT+ -ITI, or CXT− -ITI). During pre-acquisition, SCL data were assessed with a 2 (Context: CXT+, CXT−) × 2 (5HTTLPR: S+, LL) × 2 (NPSR1: T+, AA) Analysis of Variance (ANOVA). Acquisition and extinction data were analyzed separately with 2 (Context: CXT+, CXT−) × 2 (Phase: 1, 2) × 2 (NPSR1: T+, AA) × 2 (5HTTLPR: S+, LL) ANOVAs, respectively. To clarify significant main effects or interactions, F contrasts were calculated. In all analyzes, the alpha level was set at p ≤ 0.05. Effect sizes were calculated using the partial eta (η2p). On Day 1, rating data after pre-acquisition and acquisition phases of one participant (LL/T+) were missing due to technical problems.
Results
Sample Characteristics
The final sample consisted of 80 participants with 20 participants per combined genotype group (S+/T+, S+/AA, LL/T+, LL/AA). There were less homozygous, SS (n = 14) or TT (n = 15), carriers than heterozygous, SL (n = 26) or TA (n = 25), carriers. However, homozygous SS carriers were equally distributed over NPSR1 subgroups (SS/AA: n = 6; SS/TA: n = 5; SS/TT: n = 3), and homozygous TT carriers were equally distributed over 5HTTLPR subgroups (SS/TT: n = 3; SL/TT: n = 4; LL/TT: n = 8), χ2(4, N = 80) = 0.58, p = 0.97. Demographic and psychometric characteristics of genotype groups are displayed in Table 1. There were less male than female participants in the final sample (31 male, 49 female), but male participants were not statistically overrepresented in any NPSR1, χ2(1, N = 80) = 2.58, p = 0.108, or 5HTTLPR genotype group, χ2(1, N = 80) = 0.47, p = 0.491, (see Table 1). Additionally, genotype groups did not differ in age, ASI, BIS, or BAS scores (all ps > 0.2). However, AA allele carriers of the NPSR1 polymorphism reported higher trait anxiety than T+ allele carriers, F(1, 76) = 4.10, p = 0.046, η2p = 0.05.
State anxiety, negative affect, and positive affect were measured before each experimental session and analyzed with 2 (Day: 1, 2) × 2 (5HTTLPR: S+, LL) × 2 (NPSR1: T+, AA) ANOVAs. State anxiety and negative affect were not influenced by any genotype (all ps > 0.2). For positive affect, there was only a significant main effect of day, F(1, 76) = 5.31, p = 0.024, η2p= 0.07, with higher positive affect on Day 1 (M = 29.89, SD = 6.11) compared to Day 2 (M = 28.76, SD = 6.93).
Pre-Acquisition
There were neither significant differences between contexts nor any effects of genotype during pre-acquisition in SCL data (all ps > 0.2) or in anxiety ratings (all ps > 0.5).
Acquisition (Day 1)
Fear-potentiated startle
Most important, the ANOVA revealed a significant three-way interaction of Context × 5HTTLPR × NPSR1, F(1, 76) = 7.00, p = 0.010, η2p = 0.08. This interaction was driven by the fact that fear-potentiated startle in CXT+ compared to CXT− was only apparent in the carriers of both risk alleles, S+/T+, F(1, 19) = 3.94, p = 0.062, η2p = 0.17, whereas carriers of one risk allele (S+/AA, LL/T+) or of no risk allele (LL/AA) did not show differential contextual fear conditioning (all ps > 0.2). The marginal conditioning effect within the S+/T+ group was due to averaging startle responses across both acquisition phases. As characteristic for learning, the conditioning effect was significant during Acquisition 2, F(1, 19) = 6.94, p = 0.016, η2p = 0.27, but not during Acquisition 1, F(1, 19) < 1 (see Figure 3). Moreover, another relevant outcome was a main effect of phase, F(1, 76) = 3.74, p = 0.057, η2p = 0.05, which just failed to reach the significance level indicating a habituation of startle responses from Acquisition 1 (M = 4.02, SD = 4.95) to Acquisition 2 (M = 2.69, SD = 4.24).
Figure 3. Startle magnitudes during Acquisition 1 (left) and Acquisition 2 (right) on Day 1. Black bars depict differences between startle magnitudes during CXT+ (anxiety context) and ITI (intertrial–interval, corridor). White bars depict differences between startle magnitudes during CXT− (safety context) and ITI. Results are shown separately for each combined genotype group of 5HTTLPR (S+ vs. LL) and NPSR1 (T+ vs. AA) polymorphisms. Error bars represent standard error of the mean (SEM). *p < 0.05.
Skin conductance
Successful contextual fear conditioning is reflected in a significant main effect of context, F(1, 76) = 48.24, p < 0.001, η2p = 0.39, with enhanced SCL in CXT+ (M = 0.690, SD = 0.198) compared to CXT− (M = 0.679, SD = 0.198) (see Figure 4). In addition, SCL habituated from Acquisition 1 (M = 0.691, SD = 0.195) to Acquisition 2 (M = 0.677, SD = 0.203), main effect of phase F(1, 76) = 10.32, p = 0.002, η2p = 0.12. None of the main or interaction effects involving a genotype reached significance (all ps > 0.1).
Figure 4. Skin conductance level (SCL, log-transformed) of all participants during Day 1 (Pre-Acquisition, Acquisition 1 and 2) and Day 2 (Extinction 1 and 2). Black bars depict SCL during CXT+ (anxiety context). White bars depict SCL during CXT− (safety context). Error bars represent standard error of the mean (SEM). *p < 0.05, ***p < 0.001.
Anxiety rating
The ANOVA revealed significant main effects of context, F(1, 75) = 14.21, p < 0.001, η2p = 0.16, and phase, F(1, 75) = 14.74, p < 0.001, η2p = 0.16, as well as significant interactions of Context × NPSR1, F(1, 75) = 5.67, p = 0.020, η2p = 0.07, and Phase × 5HTTLPR, F(1, 75) = 7.05, p = 0.010, η2p = 0.09. The main effect of context indicated successful contextual fear conditioning; the CXT+ was rated as more anxiety eliciting (M = 25.92, SD = 26.27) than the CTX- (M = 20.23, SD = 23.37) in all participants. The main effect of phase reflected an overall decrease of anxiety from Acquisition 1 (M = 25.70, SD = 25.69) to Acquisition 2 (M = 20.45, SD = 23.68). The Context × NPSR1 interaction was due to the fact that AA carriers displayed learning. AA carriers reported higher anxiety in CXT+ compared to CXT−, F(1, 39) = 15.65, p < 0.001, η2p = 0.29, whereas T+ carriers did not, F(1, 38) = 1.19, p = 0.281, η2p = 0.03, as depicted in Figure 5. The conditioning effect in the AA group was not due to the fact that only the subgroup of S+/AA carriers exhibited higher anxiety ratings for CXT+ vs. CXT−, and not LL/AA carriers. Indeed, 5HTTLPR polymorphism had no impact on conditioning of anxiety ratings. While both S+/AA (p = 0.003) and LL/AA (p = 0.039) carriers showed differential conditioning effects, both T+ allele groups i.e., S+/T+ (p = 0.961) and LL/T+ (p = 0.160), did not. Post-hoc tests regarding the Phase × 5HTTLPR interaction revealed that anxiety ratings declined in LL carriers from Acquisition 1 (M = 30.71, SD = 26.20) to Acquisition 2 (M = 21.74, SD = 23.50), F(1, 38) = 12.43, p = 0.001, η2p = 0.25, but not in S+ carriers, F(1, 39) = 2.41, p = 0.128, η2p = 0.06, (Acquisition 1: M = 20.81, SD = 24.52; Acquisition 2: M = 19.19, SD = 24.10).
Figure 5. Anxiety ratings from 0 (no anxiety at all) to 100 (very high anxiety) after Acquisition 1 (left) and Acquisition 2 (right) on Day 1. Black bars depict ratings for CXT+ (anxiety context). White bars depict ratings for CXT− (safety context). Results are shown separately for NPSR1 genotype groups (T+ vs. AA carriers). Error bars represent standard errors of the mean (SEM). **p < 0.01, ***p < 0.001.
US-expectancy rating
There was a significant main effect of context, F(1, 75) = 246.48, p < 0.001, η2p = 0.77, and significant interactions of Phase × Context, F(1, 75) = 56.64, p < 0.001, η2p = 0.43, and Context × NPSR1 × 5HTTLPR, F(1, 75) = 5.64, p = 0.020, η2p = 0.07. After Acquisition 1 and 2, all participants rated the expectancy of receiving a US in the CXT+ (Acquisition 1: M = 74.81, SD = 25.22; Acquisition 2: M = 90.44, SD = 17.45) as higher compared to CXT− (Acquisition 1: M = 38.86, SD = 31.31; Acquisition 2: M = 19.87, SD = 26.89), F(1, 78) = 66.42, p < 0.001, η2p = 0.46, and F(1, 78) = 316.37, p < 0.001, η2p = 0.80, respectively. However, this difference increased from Acquisition 1 to Acquisition 2, F(1, 78) = 58.48, p < 0.001, η2p = 0.43, indicating successful contextual fear conditioning (see Figure 6). The Context × NPSR1 × 5HTTLPR interaction indicated that although all four combined genotype groups reported higher US-expectancy in CXT+ compared to CXT− across both acquisition phases (all ps < 0.001), S+/AA carriers displayed a greater difference in expectancy ratings between CXT+ (M = 91.00, SD = 12.55) and CXT− (M = 20.25, SD = 18.19) compared to all other combined genotype groups (all ps ≤ 0.05).
Figure 6. US-expectancy ratings from 0 (not expected at all) to 100 (definitely expected) after Acquisition 1 (left) and Acquisition 2 (right) on Day 1. Black bars depict ratings for CXT+ (anxiety context). White bars depict ratings for CXT− (safety context). Results are shown separately for each combined genotype group of 5HTTLPR (S+ vs. LL) and NPSR1 (T+ vs. AA) polymorphisms. Error bars represent standard error of the mean (SEM).
Correlation analysis
To elucidate the interaction between genotype and life stress on contextual fear conditioning and shed light on the absent conditioning effect regarding anxiety ratings in T+ allele carriers, correlations with the number of stressful life events were calculated, as stressful events were found to modulate the effects of 5HTTLPR and NPSR1 polymorphisms on levels of anxiety (Klauke et al., 2011, 2012; Klucken et al., 2013). To this end, contextual fear conditioning effects were assessed as the difference between anxiety responses in CXT+ and CXT−. These difference scores for startle and rating data were then correlated with the number of stressful life events reported by the participants. For startle data, four correlation analyses were carried out separately for each combined genotype group (S+/T+, S+/AA, LL/T+, LL/AA) since the interaction between both genotypes influenced startle data. For anxiety ratings correlation analyses were conducted separately for each NPSR1 genotype group (T+, AA), irrespective of the 5HTTLPR genotype because it had no influence on rating data. Results showed no significant correlations between conditioning effects in startle data and the number of stressful life events in any genotype group (all ps > 0.1). In contrast, the difference between anxiety ratings for CXT+ vs. CXT− correlated negatively with the number of stressful life events in the T+ allele group (r = −0.345, p = 0.032) but not in the AA allele group (r = −0.186, p = 0.251). Thus, in the T+ allele group an increase in the number of experienced life events was associated with a decrease in contextual fear conditioning as reflected in anxiety ratings (see Figure 7).
Figure 7. Scatterplots for correlations between conditioning effects in anxiety ratings on Day 1 (difference score: CXT+ - CXT−) and the number of stressful life events for NPSR1 genotype groups: risk allele carriers T+ (left) and no risk allele carriers AA (right).
Extinction (Day 2)
Fear-potentiated startle
The ANOVA revealed a significant main effect of context, F(1, 76) = 5.94, p = 0.017, η2p = 0.07, and a significant interaction of Phase × Context, F(1, 76) = 6.17, p = 0.015, η2p = 0.08, indicating successful extinction. While startle magnitudes were higher in CXT+ (M = 3.96, SD = 7.18) compared to CXT− (M = 1.93, SD = 5.46), F(1, 79) = 10.49, p = 0.002, η2p = 0.12, during Extinction 1, this effect lost significance during Extinction 2, CXT+ (M = 1.94, SD = 5.03) and CXT− (M = 1.59, SD = 5.28), F(1, 79) < 1. There were no significant interaction effects involving any genotype (all ps > 0.1). Nevertheless, since we found a modulation of both genotypes on the acquisition of fear-potentiated startle, as an exploratory operation we analyzed the time course of extinction of the four genotype groups separately (see Figure 8). During Extinction 1, carriers of only one risk allele (S+ or T+ i.e., groups S+/AA and LL/T+) showed higher startle magnitudes in CXT+ compared to CXT−, F(1, 19) = 5.84, p = 0.026, η2p = 0.24, and F(1, 19) = 4.37, p = 0.050, η2p = 0.19, respectively, whereas carriers of both risk alleles (S+/T+) and no risk allele (LL/AA) did not (all ps > 0.3). All four genotype groups extinguished fear-potentiated startle during Extinction 2 (all ps > 0.2).
Figure 8. Startle magnitudes during Extinction1 (left) and Extinction 2 (right) on Day 2. Black bars depict differences between startle magnitudes during CXT+ (anxiety context) and ITI (intertrial–interval, corridor). White bars depict differences between startle magnitudes during CXT− (safety context) and ITI. Results are shown separately for each combined genotype group of 5HTTLPR (S+ vs. LL) and NPSR1 (T+ vs. AA) polymorphisms. Error bars represent standard error of the mean (SEM). *p ≤ 0.05.
Skin conductance
SCL decreased from Extinction 1 (M = 0.635, SD = 0.235) to Extinction 2 (M = 0.622, SD = 0.228), F(1, 76) = 5.78, p = 0.019, η2p = 0.07, (main effect of phase). Additionally, there was a marginally significant interaction of Context × Phase, F(1, 76) = 3.50, p = 0.065, η2p = 0.04, indicating overall successful extinction. During Extinction 1, SCL was higher in CXT+ (M = 0.638, SD = 0.236) compared to CXT− (M = 0.632, SD = 0.234), F(1, 79) = 6.15, p = 0.015, η2p = 0.07, but this difference disappeared during Extinction 2, F(1, 79) < 1, (CXT+: M = 0.621, SD = 0.228; CXT−: M = 0.623, SD = 0.230, see Figure 4). There was also a significant main effect of 5HTTLPR genotype, F(1, 76) = 5.48, p = 0.022, η2p = 0.07, due to LL carriers having higher overall SCL during extinction (M = 0.688, SD = 0.222) compared to S+ carriers (M = 0.569, SD = 0.226).
Anxiety rating
The ANOVA revealed significant main effects of phase, F(1, 76) = 13.60, p < 0.001, η2p = 0.15, and context, F(1, 76) = 21.60, p < 0.001, η2p = 0.22, and significant interactions of Context × NPSR1, F(1, 76) = 4.71, p = 0.033, η2p = 0.06, and Phase × Context × NPSR1, F(1, 76) = 3.93, p = 0.051, η2p = 0.05. Contrasts regarding the three-way interaction showed that AA carriers reported higher anxiety ratings for CXT+ compared to CXT− after both Extinction 1, F(1, 39) = 18.88, p < 0.001, η2p = 0.33, and Extinction 2, F(1, 39) = 16.39, p < 0.001, η2p = 0.30. In contrast, T+ carriers only reported higher anxiety for CXT+ compared to CXT− after Extinction 2, F(1, 39) = 4.18, p = 0.048, η2p = 0.10, but anxiety ratings for CXT+ after Extinction 2 were higher in AA compared to T+ carriers, F(1, 78) = 4.39, p = 0.039, η2p = 0.05, (see Figure 9).
Figure 9. Anxiety ratings from 0 (no anxiety at all) to 100 (very high anxiety) after Extinction 1 (left) and Extinction 2 (right) on Day 2. Black bars depict ratings for CXT+ (anxiety context, paired with unconditioned stimulus). White bars depict ratings for CXT− (safety context). Results are shown separately for NPSR1 genotype groups (T+ vs. AA carriers). Error bars represent standard error of the mean (SEM). *p < 0.05, ***p ≤ 0.001.
US-expectancy rating
There were significant main effects of phase, F(1, 76) = 16.14, p < 0.001, η2p = 0.18, and context, F(1, 76) = 112.56, p < 0.001, η2p = 0.60, and significant interactions of Phase × Context, F(1, 76) = 27.11, p < 0.001, η2p = 0.26, and Context × NPSR1, F(1, 76) = 4.38, p = 0.040, η2p = 0.06. AA carriers reported higher US-expectancy for CXT+ (M = 63.91, SD = 19.84) compared to T+ carriers (M = 51.48, SD = 24.28) after the extinction phases, F(1, 78) = 6.29, p = 0.014, η2p = 0.08. Nevertheless AA, F(1, 39) = 86.56, p < 0.001, as well as T+ carriers, F(1, 39) = 35.54, p < 0.001, η2p= 0.48, reported higher US-expectancy in CXT+ compared to CXT− (AA: M = 25.26, SD = 24.85; T+: M = 25.56, SD = 27.08). Post-hoc contrasts regarding the Phase × Context interaction revealed that US-expectancy for CXT+ was rated as higher than for CXT− after both extinction phases (all ps < 0.001), but the difference between ratings for CXT+ and CXT− decreased from Extinction 1 to Extinction 2, F(1, 79) = 27.48, p < 0.001, η2p = 0.26, thus indicating extinction.
Discussion
The modulation of contextual fear conditioning and extinction by 5HTTLPR and NPSR1 polymorphisms were investigated with a VR paradigm with two offices rooms as conditioned contexts. Human as well as animal research suggests that the T allele of the NPSR1 polymorphism (Pape et al., 2010; Raczka et al., 2010; Domschke et al., 2011) and the S allele of the 5HTTLPR polymorphism (Canli and Lesch, 2007; Lonsdorf et al., 2009; Klumpers et al., 2012) are vulnerability factors for enhanced anxiety levels and anxiety disorders, presumably as a result of facilitated fear conditioning (Orr et al., 2000; Mineka and Oehlberg, 2008). Since contextual fear conditioning is an important model of sustained anxiety and as a characteristic of anxiety disorders, we expected that carriers of these two risk alleles would exhibit facilitated contextual fear conditioning.
First and most important, we found that contextual fear conditioning, as measured with the “non-cognitive” behavioral measure of fear-potentiated startle, is modulated by an interaction of the NPSR1 and the 5HTTLPR polymorphisms. Only participants carrying both risk alleles (S+/T+) showed enhanced startle responses in the anxiety compared to the safety context during conditioning. Since this effect was especially clear in the later acquisition phase we conclude that it reflects learning by experience. The fear-potentiated startle reflex is preserved across species and used as a translational measure of fear. This response reflects the activation of the innate defensive system mediated by the amygdala which is especially relevant for implicit and automatic fear learning (Mineka and Öhman, 2002; Hamm and Weike, 2005). Therefore, the gene × gene interaction on the fear-potentiated startle reflex further underscores the importance of both polymorphisms and transmitter systems in amygdala-dependent fear learning. Furthermore, this heightened behavioral expression of conditioned contextual anxiety in carriers of the S+ and the T+ allele might function as an endophenotype of anxiety disorders, particularly those characterized by sustained anxiety levels. Supporting this view, firstly studies by Grillon et al. (2008, 2009) revealed that panic disorder and PTSD are characterized by enhanced contextual anxiety, as indicated by fear-potentiated startle. Secondly, disease-specific genetic associations between 5HTTLPR and PTSD (Kolassa et al., 2010; Wang et al., 2011) and between NPSR1 and panic disorder (Domschke et al., 2011) were reported. Interestingly, 24 h after consolidation of the fear memory, only carriers of one risk allele (S+/AA, T+/LL) exhibited conditioned startle discrimination, whereas the fear-potentiated startle was already extinguished in carriers of both risk alleles. Carrying both risk alleles not only seems to facilitate fear learning but also to speed up fear extinction on a behavioral level. In contrast, carrying one risk allele seems to delay the expression of contextual fear.
Second, our results indicate successful contextual fear conditioning as reflected in enhanced physiological arousal (SCL, Figure 4) in the anxiety context compared to the safety context. Skin conductance effects are frequently interpreted as a reliable indicator of successful learning in cued (Olsson and Phelps, 2004; Schiller et al., 2010; Tabbert et al., 2011) as well as contextual fear conditioning (Tröger et al., 2012; Glotzbach-Schoon et al., 2013). However, we found no modulation of this conditioning effect by the examined genetic polymorphisms. SCL did also not differ between genotype groups before the experiment (i.e., during the pre-acquisition phase), suggesting an equal arousal level among all participants. Since previous studies on cue conditioning also could not find any modulation of conditioned SCR by 5HTTLPR or NPSR1 polymorphisms (Lonsdorf et al., 2009; Raczka et al., 2010; Klucken et al., 2013), it might be concluded that skin conductance is rarely influenced by these genetic variants. Differential skin conductance responses in fear conditioning presumably depend on contingency awareness i.e., the explicitly learned association between CS and US (Hamm and Vaitl, 1996), and participants in the present study were very well aware of the contingencies (see US-expectancy rating, Figure 6). As a matter of fact, US-expectancy ratings and SCL revealed contextual fear conditioning effects already in the first acquisition phase indicating that participants cognitively apprehended contingencies quite early. Therefore, it seems reasonable to conclude that genetic influences on SCL cannot be expected, at least if the contingencies are clear and easily apprehended, as in the present study.
Surprisingly, we found an influence of NPSR1 but no interaction between both polymorphisms on explicit anxiety ratings. AA carriers (no risk allele) reported higher anxiety in the anxiety context compared to the safety context after contextual fear conditioning. This differential learning effect could still be found during extinction on Day 2. Presumably, as a result of this enhanced conditioning effect in AA carriers, extinction of explicit anxiety ratings was delayed in AA carriers too. Notably, US-expectancy ratings for CXT+ were also higher in AA compared to T+ carriers after extinction. This might be a hint for fast contextual fear conditioning in combination with extinction deficits in AA carriers on a verbal, explicit level. This result stands in contrast to the enhanced conditioning effects of fear-potentiated startle in S+ and T+ carriers in our study.
To explain this finding three points have to be considered. Firstly, a fear response can vary on two levels: an implicit behavioral level (i.e., fear-potentiated startle reflex) vs. an explicit/cognitive level (i.e., verbal ratings) (Hamm and Weike, 2005). These two levels can be influenced independently from another and even dissociate. Diverging responses on explicit and implicit levels have already been reported in the fields of fear extinction (Vansteenwegen et al., 1998) and pain relief learning (Andreatta et al., 2010). Here, we found a dissociation of implicit and explicit levels of fear according to the NPSR1 genotype. T+ allele carriers (in addition with a S+ allele of the 5HTTLPR genotype) exhibited fear-potentiated startle but no explicit anxiety, whereas AA allele carriers showed no fear-potentiated startle but reported explicit anxiety. In any case, our results emphasize the importance of measuring different fear levels.
Secondly, it should be noted that AA compared to T+ carriers reported higher arousal triggered by the US. This difference in the explicit evaluation of the US might have contributed to the differential conditioning effects in explicit anxiety ratings in AA but not T+ carriers. To confirm whether US-arousal was associated with anxiety ratings and not startle data, we correlated differential conditioning effects in anxiety ratings and startle data with US-arousal. Interestingly, we found a significant positive correlation between US-arousal and the amount of differential conditioning in anxiety ratings but not with differential conditioning effects in fear-potentiated startle1. Thus, US-arousal might have had a greater impact on the explicit level than on the implicit fear-potentiated startle response.
Thirdly, an interaction between stress and the NPS system has been reported in two rodent (Ebner et al., 2011; Jüngling et al., 2012) and one human study (Klauke et al., 2012). In line with this research, in our study the conditioning effect in explicit anxiety ratings was not only influenced by NPSR1 genotype but additionally by the amount of stressful life events. In detail, there was a negative correlation between the contextual fear conditioning effect on the explicit anxiety level and the number of stressful life events. This negative association could only be found in T+ carriers, meaning that the higher the number of stressful life events is the weaker is the conditioning effect. T+ risk allele carriers with many life events even tended to rate the safety context as more anxiety inducing than the anxiety context. Notably, not only faster and higher fear conditionability is discussed as a diathesis for anxiety disorders (Orr et al., 2000), but also the failure to inhibit fear responses in the presence of safety (Lissek et al., 2005, 2009). Carrying the T risk allele in addition to high amounts of life stress might impair safety learning on a cognitive explicit level. However, this is very speculative as participants were not pre-selected on the basis of life events and this negative association has to be replicated in larger samples.
A limitation of our study might be that fear-potentiated startle effects were not very strong and could not be seen across all 80 participants but only in the high risk subgroup. The reasons for this discrepancy might be that we did not realize enough learning trials or that the US was not aversive enough. However, our paradigm was effective enough to evoke fast contextual anxiety in carriers of the two risk alleles for anxiety disorders, whereas carriers of only one risk allele showed delayed fear expression. We suggest that future studies should use our paradigm to examine a more anxious sample perhaps revealing stronger conditioning effects (Glotzbach-Schoon et al., 2013) especially on the cognitive level in T+ allele carriers as well.
In summary, we found an effect of both risk alleles of the 5HTTLPR and the NPSR1 polymorphisms on the acquisition of contextual fear measured with an implicit behavioral measure, the fear-potentiated startle. On an explicit level, the examined 5HTTLPR polymorphism had no effect on anxiety ratings. Only the no risk allele carriers of the NPSR1 genotype exhibited differential contextual fear conditioning and extinction deficits on an explicit level. The serotonin system might only modulate amygdala-dependent fear learning but not the explicit evaluation of a threatening context, whereas the NPS system might have opposing effects on explicit and implicit anxiety responses. Further studies are needed to elucidate the role of the NPSR1 in explicit and implicit contextual fear conditioning. However, we demonstrated that both genetic polymorphisms play an important role in contextual fear conditioning which is a model for unpredictable threat and sustained anxiety characteristic for panic disorder or PTSD. In conclusion, enhanced contextual fear conditioning may function as an endophenotype for these anxiety disorders.
Conflict of Interest Statement
Prof. Paul Pauli is shareholder of a commercial company that develops virtual environment research systems for empirical studies in the field of psychology, psychiatry, and psychotherapy. Prof. Andreas Mühlberger is shareholder and executive officer of the same company. The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
This work is part of the dissertation of Evelyn Glotzbach-Schoon. It was supported by the Deutsche Forschungsgemeinschaft (DFG): Collaborative Research Center “Fear, Anxiety, Anxiety Disorders,” SFB-TRR 58 sub-project B01 to Paul Pauli and Andreas Mühlberger and sub-project Z02 to Jürgen Deckert, Andreas Reif, and Paul Pauli and by the DFG and the University of Würzburg in the funding program Open Access Publishing. We thank Gerald Wiele and Ramona Baur for assistance in data collection, and Caro Gagel, Mathias Müller, and Peter Lenz for their excellent technical assistance.
Footnotes
- ^Differential conditioning effects in anxiety ratings and startle data were assessed as the difference score between anxiety ratings/startle response in CXT+ and CXT− at Day 1. Correlation between anxiety ratings and US-arousal: r = 0.223, p = 0.047; and between startle response and US-arousal: r = 0.074, p = 0.512.
References
Ackenheil, M., Stotz, G., Dietz-Bauer, R., and Vossen, A. (1999). Deutsche Fassung des Mini-International Neuropsychiatric Interview. München: Psychiatrische Universitätsklinik München.
Alpers, G. W., and Pauli, P. (2001). Angstsensitivitäts-Index. Würzburg: Julius-Maximilians-Universität.
Alvarez, R. P., Biggs, A., Chen, G., Pine, D. S., and Grillon, C. (2008). Contextual fear conditioning in humans: cortical-hippocampal and amygdala contributions. J. Neurosci. 28, 6211–6219.
Alvarez, R. P., Chen, G., Bodurka, J., Kaplan, R., and Grillon, C. (2011). Phasic and sustained fear in humans elicits distinct patterns of brain activity. Neuroimage 55, 389–400.
Amstadter, A. B., Nugent, N. R., and Koenen, K. C. (2009). Genetics of PTSD: fear conditioning as a model for future research. Psychiatr. Ann. 39, 358–367.
Andreatta, M., Mühlberger, A., Yarali, A., Gerber, B., and Pauli, P. (2010). A rift between implicit and explicit conditioned valence in human pain relief learning. Proc. Biol. Sci. 277, 2411–2416.
Barot, S. K., Chung, A., Kim, J. J., and Bernstein, I. L. (2009). Functional imaging of stimulus convergence in amygdalar neurons during Pavlovian fear conditioning. PLoS ONE 4:e6156. doi: 10.1371/journal.pone.0006156
Blumenthal, T. D., Cuthbert, B. N., Filion, D. L., Hackley, S., Lipp, O. V., and Van Boxtel, A. (2005). Committee report: guidelines for human startle eyeblink electromyographic studies. Psychophysiology 42, 1–15.
Bradley, M. M., and Lang, P. J. (2007). “Emotion and motivation,” in Handbook of Psychophysiology, eds J. T. Cacioppo, L. G. Tassinary, and G. G. Berntson (New York, NY: Cambridge University Press), 581–607.
Canli, T., and Lesch, K.-P. (2007). Long story short: the serotonin transporter in emotion regulation and social cognition. Nat. Neurosci. 10, 1103–1109.
Canli, T., Qiu, M., Omura, K., Congdon, E., Haas, B. W., Amin, Z., et al. (2006). Neural correlates of epigenesis. Proc. Natl. Acad. Sci. U.S.A. 103, 16033–16038.
Carver, C. S., and White, T. L. (1994). Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: the BIS/BAS Scales. J. Pers. Soc. Psychol. 67, 319–333.
Dai, J.-X., Han, H.-L., Tian, M., Cao, J., Xiu, J.-B., Song, N.-N., et al. (2008). Enhanced contextual fear memory in central serotonin-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 105, 11981–11986.
Dannlowski, U., Konrad, C., Kugel, H., Zwitserlood, P., Domschke, K., Schöning, S., et al. (2010). Emotion specific modulation of automatic amygdala responses by 5-HTTLPR genotype. Neuroimage 53, 893–898.
Dannlowski, U., Kugel, H., Franke, F., Stuhrmann, A., Hohoff, C., Zwanzger, P., et al. (2011). Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli. Neuropsychopharmacology 36, 1879–1885.
Davis, M. (2006). Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am. Psychol. 61, 741–756.
Domschke, K., Gajewska, A., Winter, B., Herrmann, M. J., Warrings, B., Mühlberger, A., et al. (2012). ADORA2A gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex. Neuropsychopharmacology 37, 759–769.
Domschke, K., Reif, A., Weber, H., Richter, J., Hohoff, C., Ohrmann, P., et al. (2011). Neuropeptide S receptor gene–converging evidence for a role in panic disorder. Mol. Psychiatry 16, 938–948.
Ebner, K., Rjabokon, A., Pape, H.-C., and Singewald, N. (2011). Increased in vivo release of neuropeptide S in the amygdala of freely moving rats after local depolarization and emotional stress. Amino Acids 41, 991–996.
Fendt, M., Buchi, M., Bürki, H., Imobersteg, S., Ricoux, B., Suply, T., et al. (2011). Neuropeptide S receptor deficiency modulates spontaneous locomotor activity and the acoustic startle response. Behav. Brain Res. 217, 1–9.
Fendt, M., and Fanselow, M. S. (1999). The neuroanatomical and neurochemical basis of conditioned fear. Neurosci. Biobehav. Rev. 23, 743–760.
Fendt, M., Imobersteg, S., Bürki, H., McAllister, K. H., and Sailer, A. W. (2010). Intra-amygdala injections of neuropeptide S block fear-potentiated startle. Neurosci. Lett. 474, 154–157.
Glotzbach, E., Ewald, H., Andreatta, M., Pauli, P., and Mühlberger, A. (2012). Contextual fear conditioning predicts subsequent avoidance behavior in a virtual reality environment. Cogn. Emot. 26, 1256–1272.
Glotzbach-Schoon, E., Tadda, R., Andreatta, M., Tröger, C., Ewald, H., Grillon, C., et al. (2013). Enhanced discrimination between threatening and safe contexts in high-anxious individuals. Biol. Psychol. 93, 159–166.
Gordon, J. A., and Hen, R. (2004). Genetic approaches to the study of anxiety. Annu. Rev. Neurosci. 27, 193–222.
Grillon, C. (2002). Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology. Biol. Psychiatry 52, 958–975.
Grillon, C. (2008). Models and mechanisms of anxiety: evidence from startle studies. Psychopharmacology 199, 421–437.
Grillon, C., Lissek, S., Rabin, S., McDowell, D., Dvir, S., and Pine, D. S. (2008). Increased anxiety during anticipation of unpredictable but not predictable aversive stimuli as a psychophysiologic marker of panic disorder. Am. J. Psychiatry 165, 898–904.
Grillon, C., Pine, D. S., Lissek, S., Rabin, S., Bonne, O., and Vythilingam, M. (2009). Increased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder. Biol. Psychiatry 66, 47–53.
Hamm, A. O., and Vaitl, D. (1996). Affective learning: awareness and aversion. Psychophysiology 33, 698–710.
Hamm, A. O., and Weike, A. I. (2005). The neuropsychology of fear learning and fear regulation. Int. J. Psychophysiol. 57, 5–14.
Hamm, A. O., Weike, A. I., Schupp, H. T., Treig, T., Dressel, A., and Kessler, C. (2003). Affective blindsight: intact fear conditioning to a visual cue in a cortically blind patient. Brain 126, 267–275.
Hariri, A. R., and Holmes, A. (2006). Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn. Sci. 10, 182–191.
Hariri, A. R., Mattay, V. S., Tessitore, A., Kolachana, B., Fera, F., Goldman, D., et al. (2002). Serotonin transporter genetic variation and the response of the human amygdala. Science 297, 400–403.
Heinz, A., Braus, D. F., Smolka, M. N., Wrase, J., Puls, I., Hermann, D., et al. (2005). Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat. Neurosci. 8, 20–21.
Herrmann, M. J., Würflein, H., Schreppel, T., Koehler, S., Mühlberger, A., Reif, A., et al. (2009). Catechol-O-methyltransferase Val(158)Met genotype affects neural correlates of aversive stimuli processing. Cogn. Affect. Behav. Neurosci. 9, 168–172.
Hettema, J. M., Annas, P., Neale, M. C., Kendler, K. S., and Fredrikson, M. (2003). A twin study of the genetics of fear conditioning. Arch. Gen. Psychiatry 60, 702–708.
Jüngling, K., Liu, X., Lesting, J., Coulon, P., Sosulina, L., Reinscheid, R. K., et al. (2012). Activation of neuropeptide S-expressing neurons in the locus coeruleus by corticotropin-releasing factor. J. Physiol. 590, 3701–3717.
Jüngling, K., Seidenbecher, T., Sosulina, L., Lesting, J., Sangha, S., Clark, S. D., et al. (2008). Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala. Neuron 59, 298–310.
Klauke, B., Deckert, J., Reif, A., Pauli, P., Zwanzger, P., Baumann, C., et al. (2011). Serotonin transporter gene and childhood trauma–a G × E effect on anxiety sensitivity. Depress. Anxiety 28, 1048–1057.
Klauke, B., Deckert, J., Zwanzger, P., Baumann, C., Arolt, V., Pauli, P., et al. (2012). Neuropeptide S receptor gene (NPSR) and life events: G × E effects on anxiety sensitivity and its subdimensions. World J. Biol. Psychiatry doi: 10.3109/15622975.2011.646302. [Epub ahead of print].
Klucken, T., Alexander, N., Schweckendiek, J., Merz, C. J., Kagerer, S., Osinsky, R., et al. (2013). Individual differences in neural correlates of fear conditioning as a function of 5-HTTLPR and stressful life events. Soc. Cogn. Affect. Neurosci. 8, 318–325.
Klumpers, F., Heitland, I., Oosting, R. S., Kenemans, J. L., and Baas, J. M. P. (2012). Genetic variation in serotonin transporter function affects human fear expression indexed by fear-potentiated startle. Biol. Psychol. 89, 277–282.
Kolassa, I.-T., Ertl, V., Eckart, C., Gloeckner, F., Kolassa, S., Papassotiropoulos, A., et al. (2010). Association study of trauma load and SLC6A4 promoter polymorphism in Posttraumatic Stress Disorder: evidence from survivors of the Rwandan genocide. J. Clin. Psychiatry 71, 543–547.
Krohne, H. W., Egloff, B., Kohlmann, C.-W., and Tausch, A. (1996). Untersuchungen mit einer deutschen Version der “Positive and Negative Affect Schedule” (PANAS). Diagnostica 42, 139–156.
Lang, P. J., Bradley, M. M., and Cuthbert, B. N. (1990). Emotion, attention, and the startle reflex. Psychol. Rev. 97, 377–395.
Laux, L., Glanzmann, P., Schaffner, P., and Spielberger, C. D. (1981). Das State-Trait-Angstinventar [The State-Trait-Anxiety-Inventory]. Weinheim: Beltz.
Leonardo, E. D., and Hen, R. (2006). Genetics of affective and anxiety disorders. Annu. Rev. Psychol. 57, 117–137.
Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527–1531.
Lissek, S., Powers, A. S., McClure, E. B., Phelps, E. A., Woldehawariat, G., Grillon, C., et al. (2005). Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav. Res. Ther. 43, 1391–1424.
Lissek, S., Rabin, S. J., McDowell, D. J., Dvir, S., Bradford, D. E., Geraci, M., et al. (2009). Impaired discriminative fear-conditioning resulting from elevated fear responding to learned safety cues among individuals with panic disorder. Behav. Res. Ther. 47, 111–118.
Lonsdorf, T. B., and Kalisch, R. (2011). A review on experimental and clinical genetic associations studies on fear conditioning, extinction and cognitive-behavioral treatment. Transl. Psychiatry 1:e41. doi: 10.1038/tp.2011.36
Lonsdorf, T. B., Weike, A. I., Nikamo, P., Schalling, M., Hamm, A. O., and Öhman, A. (2009). Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder. Psychol. Sci. 20, 198–206.
Luyten, L., van Kuyck, K., Vansteenwegen, D., and Nuttin, B. (2011). Electrolytic lesions of the bed nucleus of the stria terminalis disrupt freezing and startle potentiation in a conditioned context. Behav. Brain Res. 222, 357–362.
Marschner, A., Kalisch, R., Vervliet, B., Vansteenwegen, D., and Büchel, C. (2008). Dissociable roles for the hippocampus and the amygdala in human cued versus context fear conditioning. J. Neurosci. 28, 9030–9036.
Meis, S., Bergado-Acosta, J. R., Yanagawa, Y., Obata, K., Stork, O., and Munsch, T. (2008). Identification of a neuropeptide S responsive circuitry shaping amygdala activity via the endopiriform nucleus. PLoS ONE 3:e2695. doi: 10.1371/journal.pone.0002695
Melchior, M., Caspl, A., Milne, B. J., Danese, A., Poulton, R., and Moffitt, T. E. (2007). Work stress precipitates depression and anxiety in young, working women and men. Psychol. Med. 37, 1119–1129.
Merrill, K. A., Steinmetz, J. E., Viken, R. J., and Rose, R. J. (1999). Genetic influences on human conditionability: a twin study of the conditioned eyeblink response. Behav. Genet. 29, 95–102.
Mineka, S., and Oehlberg, K. (2008). The relevance of recent developments in classical conditioning to understanding the etiology and maintenance of anxiety disorders. Acta Psychol. 127, 567–580.
Mineka, S., and Öhman, A. (2002). Phobias and preparedness: the selective, automatic, and encapsulated nature of fear. Biol. Psychiatry 52, 927–937.
Mineka, S., and Zinbarg, R. (2006). A contemporary learning theory perspective on the etiology of anxiety disorders: it's not what you thought it was. Am. Psychol. 61, 10–26.
Nugent, N. R., Tyrka, A. R., Carpenter, L. L., and Price, L. H. (2011). Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology 214, 175–196.
Olsson, A., and Phelps, E. A. (2004). Learned fear of “unseen” faces after Pavlovian, observational, and instructed fear. Psychol. Sci. 15, 822–828.
Orr, S. P., Metzger, L. J., Lasko, N. B., Macklin, M. L., Peri, T., and Pitman, R. K. (2000). De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder. J. Abnorm. Psychol. 109, 290–298.
Pape, H.-C., Jüngling, K., Seidenbecher, T., Lesting, J., and Reinscheid, R. K. (2010). Neuropeptide S: a transmitter system in the brain regulating fear and anxiety. Neuropharmacology 58, 29–34.
Raczka, K. A., Gartmann, N., Mechias, M.-L., Reif, A., Büchel, C., Deckert, J., et al. (2010). A neuropeptide S receptor variant associated with overinterpretation of fear reactions: a potential neurogenetic basis for catastrophizing. Mol. Psychiatry 15, 1067–1074.
Reinscheid, R. K., Xu, Y.-L., Okamura, N., Zeng, J., Chung, S., Pai, R., et al. (2005). Pharmacological characterization of human and murine neuropeptide S receptor variants. J. Pharmacol. Exp. Ther. 315, 1338–1345.
Reiss, S., Peterson, R. A., Gursky, D. M., and McNally, R. J. (1986). Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav. Res.Ther. 24, 1–8.
Schiller, D., Monfils, M.-H., Raio, C. M., Johnson, D. C., Ledoux, J. E., and Phelps, E. A. (2010). Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 463, 49–53.
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59, 22–33.
Skelton, K., Ressler, K. J., Norrholm, S. D., Jovanovic, T., and Bradley-Davino, B. (2012). PTSD and gene variants: new pathways and new thinking. Neuropharmacology 62, 628–637.
Spielberger, C. D., Gorsuch, R. L., and Edward, L. R. (1970). STAI Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
Strobel, A., Beauducel, A., Debener, S., and Brocke, B. (2001). Eine deutschsprachige Version des BIS/BAS-Fragebogens von Carver und White. Z. Diff. Diagn. Psychol. 22, 216–227.
Tabbert, K., Merz, C. J., Klucken, T., Schweckendiek, J., Vaitl, D., Wolf, O. T., et al. (2011). Influence of contingency awareness on neural, electrodermal and evaluative responses during fear conditioning. Soc. Cogn. Affect. Neurosci. 6, 495–506.
Tröger, C., Ewald, H., Glotzbach, E., Pauli, P., and Mühlberger, A. (2012). Does pre-exposure inhibit fear context conditioning? A Virtual Reality Study. J. Neural Transm. 119, 709–719.
Vansteenwegen, D., Crombez, G., Baeyens, F., and Eelen, P. (1998). Extinction in fear conditioning: Effects on startle modulation and evaluative self-reports. Psychophysiology 35, 729–736.
Wang, Z., Baker, D. G., Harrer, J., Hamner, M., Price, M., and Amstadter, A. (2011). The relationship between combat-related posttraumatic stress disorder and the 5-HTTLPR/rs25531 polymorphism. Depress. Anxiety 28, 1067–1073.
Watanabe, A., Nakao, K., Tokuyama, M., and Takeda, M. (2005). Prediction of first episode of panic attack among white-collar workers. Psychiatry Clin. Neurosci. 59, 119–126.
Watson, D., Clark, L. A., and Tellegen, A. (1988). Development and validation of brief measures of positive and negative affect: The PANAS scales. J. Pers. Soc. Psychol. 54, 1063–1070.
Keywords: 5HTTLPR, NPSR1, gene × gene interaction, contextual fear conditioning, fear-potentiated startle
Citation: Glotzbach-Schoon E, Andreatta M, Reif A, Ewald H, Tröger C, Baumann C, Deckert J, Mühlberger A and Pauli P (2013) Contextual fear conditioning in virtual reality is affected by 5HTTLPR and NPSR1 polymorphisms: effects on fear-potentiated startle. Front. Behav. Neurosci. 7:31. doi: 10.3389/fnbeh.2013.00031
Received: 14 January 2013; Paper pending published: 09 March 2013;
Accepted: 01 April 2013; Published online: 23 April 2013.
Edited by:
Inga D. Neumann, University of Regensburg, GermanyReviewed by:
Francesca Cirulli, Istituto Superiore di Sanità, ItalyHarmen J. Krugers, Universiteit van Amsterdam, Netherlands
Copyright © 2013 Glotzbach-Schoon, Andreatta, Reif, Ewald, Tröger, Baumann, Deckert, Mühlberger and Pauli. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
*Correspondence: Paul Pauli, Department of Psychology I, Biological Psychology, Clinical Psychology, and Psychotherapy, University of Würzburg, Marcusstr. 9-11, 97070 Würzburg, Germany. e-mail: pauli@psychologie.uni-wuerzburg.de